37.7
Gain Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
21.1
FY23:
17.8
FY24:
11.6
FY25:
22.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.26
FY22:
3.01
FY23:
0.83
FY24:
0.52
FY25:
0.58
Total assets
Change from FY21 to FY25
millions USD
FY21:
39.0
FY22:
24.1
FY23:
18.6
FY24:
12.1
FY25:
22.8
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.55
FY22:
4.13
FY23:
4.95
FY24:
3.91
FY25:
3.35
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.61
FY22:
1.09
FY23:
1.08
FY24:
0.87
FY25:
0.90
(positive)
Change from FY21 to FY25
millions USD
FY21:
34.8
FY22:
18.9
FY23:
12.6
FY24:
7.34
FY25:
18.6
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
39.0
FY22:
24.1
FY23:
18.6
FY24:
12.1
FY25:
22.8
All amounts in millions USD